BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2780
-0.0070 (-2.46%)
At close: Apr 2, 2026, 4:00 PM EDT
0.2744
-0.0036 (-1.29%)
After-hours: Apr 2, 2026, 7:58 PM EDT
BioRestorative Therapies Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for BioRestorative Therapies in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for BioRestorative Therapies.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | +6,374.82% | Aug 14, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +5,295.68% | Jun 12, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +5,295.68% | Aug 14, 2023 |
| Roth Capital | Roth Capital | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +5,295.68% | Dec 7, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +2,058.27% | Sep 28, 2022 |
Financial Forecast
Revenue This Year
1.94M
from 359.70K
Increased by 438.78%
Revenue Next Year
2.36M
from 1.94M
Increased by 21.72%
EPS This Year
-0.77
from -1.58
EPS Next Year
-0.64
from -0.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.6M | 3.3M | |||
| Avg | 1.9M | 2.4M | |||
| Low | 1.3M | 1.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 629.8% | 69.3% | |||
| Avg | 438.8% | 21.7% | |||
| Low | 254.2% | -24.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.35 | -0.30 | |||
| Avg | -0.77 | -0.64 | |||
| Low | -1.15 | -0.95 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.